Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03220711 · ClinicalTrials.gov registry record · NA
Study of Performance of Confocal Endomicroscope With Fluorescein Imaging Agent in the Colon
A NA study, sponsored by University of Michigan.
- Terminated
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT03220711 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 72 participants.
The verdict
NCT03220711, a NA study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
The overall aim of this research project is to evaluate the imaging performance of a confocal endomicroscope. Fluorescein, an FDA-approved topical fluorescent dye, will be used to provide topical mucosal contrast. The purpose of this instrument is to provide real-time endoscopic "histology" to guide endoscopic biopsy or endoscopic mucosal resection (EMR) in the patient study group. This endomicroscope probe will be used during colonoscopies in subjects with colonic dysplasia, known colonic adenomatous polyps scheduled for endoscopic resection, or suspected dysplasia in subjects with Inflammatory Bowel Disease (IBD).
Interventions
- DRUG Fluorescein
- DEVICE confocal endomicroscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2017-07-28 |
| Est. Completion | 2022-06-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03220711
The ClinicalTrials.gov registry entry for NCT03220711 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fluorescein is the first listed.
NCT03220711 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03220711 about?
NCT03220711 is a clinical study titled "Study of Performance of Confocal Endomicroscope With Fluorescein Imaging Agent in the Colon". The overall aim of this research project is to evaluate the imaging performance of a confocal endomicroscope. Fluorescein, an FDA-approved topical fluorescent dye, will be used to provide topical mucosal contrast. The purpose of this instrument is to provide real-time endoscopic "histology" to guide...
What is the current status of trial NCT03220711?
This trial is currently terminated. It is a NA study. The enrollment target is 72 participants. The study started on 2017-07-28. Estimated completion is 2022-06-02.
What interventions are being tested in trial NCT03220711?
The interventions under investigation include: Fluorescein (DRUG), confocal endomicroscope (DEVICE).
Who is sponsoring clinical trial NCT03220711?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.